VectOr ChAnge defibriLlatIon in Refractory Shockable rhyThms
VOCALIST
Vector Change Defibrillation in Refractory Shockable Rhythms
1 other identifier
observational
50
1 country
1
Brief Summary
Management of cardiac arrest according to published guidelines has remained largely unchanged for a decade. Thames Valley Air Ambulance provide Critical Care Paramedic and Physician teams who respond to cardiac arrests and offer treatments beyond the scope of ambulance service clinicians. Following a review of practice and appraisal of evidence the investigators developed an additional algorithm for cases of adult medical cardiac arrest with refractory shockable rhythms. This adds to but does not replace the Advanced Life Support algorithm and includes:
- Delivering shocks with the LUCAS mechanical CPR device running
- After 5 shocks have been delivered placing new pads in the Anterior Posterior (AP) position
- Delivering shocks using the TVAA Tempus Pro defibrillator rather than the Ambulance Service defibrillator. This bundle was based on recommendations from ILCOR and the Resus Council (UK) Advanced Life Support manual and was launched in October 2021.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2023
CompletedFirst Submitted
Initial submission to the registry
May 22, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2023
CompletedFirst Posted
Study publicly available on registry
July 3, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2023
CompletedJuly 3, 2023
June 1, 2023
2 months
May 22, 2023
June 21, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
ROSC at hospital
ROSC at hospital
within 24 hours of arrest
Secondary Outcomes (1)
PLE rate
within 24 hours of arrest
Other Outcomes (1)
Total defibrillation shocks
within 24 hours of arrest
Study Arms (2)
Before intervention
Standard care as per ALS guidelines prior to October 2021
After intervention
Enhanced cardiac arrest management as per TVAA guideline from October 2021 onwards
Interventions
* Delivering shocks with the LUCAS mechanical CPR device running * After 5 shocks have been delivered placing new pads in the Anterior Posterior (AP) position * Delivering shocks using the TVAA Tempus Pro defibrillator rather than the Ambulance Service defibrillator.
Eligibility Criteria
Adult patients with medical cardiac arrest attended by TVAA, in refractory shockable rhythms (defined as continuous VF or VT after 5 shocks).
You may qualify if:
- adult patients with medical cardiac arrest
- in refractory shockable rhythms (defined as continuous VF or VT after 5 shocks).
You may not qualify if:
- traumatic cardiac arrests
- cardiac arrests where the VF/VT was recurrent (could be terminated but then restarted) rather than refractory (unable to get the patient out of the shockable rhythm). Refractory VF refers to VF that persists despite shock delivery (i.e. shock-resistant VF). This is distinguished from recurrent VF, which is VF that re-appears after it has been terminated (2). In this study refractory would be defined as continuous VF or VT after 5 shocks.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Thames Valley Air Ambulance
Oxford, Oxfordshire, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Audit, Improvement and Research Lead
Study Record Dates
First Submitted
May 22, 2023
First Posted
July 3, 2023
Study Start
May 1, 2023
Primary Completion
June 30, 2023
Study Completion
September 1, 2023
Last Updated
July 3, 2023
Record last verified: 2023-06
Data Sharing
- IPD Sharing
- Will not share
No individual patient data to be shared